Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Preview: Maia Biotechnology, Inc. Set To IPO Tomorrow

MAIA Biotechnology, Inc. (NASDAQ:MAIA) IPO will take place July, 28 on the NASDAQ exchange under the ticker MAIA. The company is offering shares at an expected price between $5.00 and $7.00 per share with an insider lock-up period of 180 days ending on January 24, 2023.
byBenzinga Insights
July 27, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

MAIA Biotechnology, Inc. (NASDAQ:MAIA) IPO will take place July, 28 on the NASDAQ exchange under the ticker MAIA.

The company is offering shares at an expected price between $5.00 and $7.00 per share with an insider lock-up period of 180 days ending on January 24, 2023.

See also: Benzinga IPO Calendar

About MAIA Biotechnology, Inc.

MAIA Biotechnology, Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO, our lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity.

See also: Benzinga’s Most Shorted Stocks

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

HeartCore Signs 14th Go IPO Contract; HeartCore Expects To Generate From Koei Shoji An Aggregate Of $500,000 In Initial Fees, Also Received A Warrant To Acquire 3% Of Koei Shoji’s Common Stock, On A Fully Diluted Basis

By Benzinga Newsdesk
April 15, 8:32 AM
HeartCore Enterprises, Inc. (NASDAQ:HTCR) ("HeartCore" or the "Company"), a leading enterprise software and consulting services company based in Tokyo, announced that it has signed an agreement ("Consulting Agreement")

HTCR